“Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model”. International Journal of Environmental Sciences 11, no. 12s (June 18, 2025): 1360–1367. Accessed March 15, 2026. https://theaspd.com/index.php/ijes/article/view/2559.